Can sertraline (Zoloft) cause or worsen tics?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sertraline Can Cause Tics, Though This is Uncommon

While tics are not listed among the common adverse reactions in sertraline's FDA labeling, sertraline can indeed cause or worsen tics in susceptible individuals, though this occurs rarely. The FDA label for Zoloft (sertraline) lists tremor as a common adverse reaction (9% vs 2% placebo) but does not specifically mention tics 1. However, post-marketing surveillance and case reports have documented this phenomenon.

Evidence for Sertraline-Induced Tics

Case reports and clinical observations confirm that sertraline can trigger tics:

  • A 2023 case report described a 16-year-old girl who developed severe motor tics immediately after starting sertraline for anxiety and depression, with complete resolution upon discontinuation 2. This case demonstrated a clear dose-response relationship and immediate onset—unusual compared to previous reports.

  • Another case documented tics emerging during both escitalopram and sertraline treatment, attributed to imbalances in dopaminergic neurotransmission 3.

  • Real-world pharmacovigilance analysis of the FAERS database (2004-2024) identified various neurologic and psychiatric adverse events with sertraline, though tics were not among the most commonly reported 4.

Clinical Context: Tics and Comorbid Conditions

The relationship between sertraline and tics becomes more complex in patients with pre-existing tic disorders:

  • In pediatric OCD patients with comorbid tic disorders, sertraline showed reduced efficacy compared to cognitive-behavioral therapy (CBT). When tics were present, sertraline did not differ significantly from placebo, whereas CBT remained effective 5.

  • Conversely, in OCD patients who failed initial CBT, those with comorbid tic disorders benefited more from sertraline than from continued CBT 6.

This suggests sertraline's relationship with tics is bidirectional: it may occasionally induce tics in previously unaffected individuals, while also potentially helping some patients with pre-existing tic disorders when used appropriately.

Mechanism and Risk Factors

The proposed mechanism involves serotonergic augmentation indirectly modulating dopamine concentrations in fronto-striatal circuits, potentially triggering tics in susceptible individuals 7. This is similar to mechanisms proposed for other antidepressants that have been associated with tics.

Clinical Recommendations

If tics emerge during sertraline treatment:

  • Discontinue sertraline immediately if new-onset tics develop, as cessation typically leads to resolution 2.

  • Consider alternative SSRIs—the case report noted successful substitution with paroxetine without tic recurrence, though whether this represents a class effect or individual variation remains unclear 2.

  • Monitor closely during the first weeks of treatment, as tics may emerge early (though delayed onset has also been reported).

For patients with pre-existing tic disorders requiring OCD treatment:

  • Prioritize CBT as first-line therapy, either alone or in combination with sertraline 5.
  • If medication is necessary, combination therapy (CBT + sertraline) appears superior to sertraline monotherapy in this population.

Important Caveats

While tremor is a recognized common adverse effect of sertraline (9% incidence), frank tics remain rare and are not included in the standard FDA labeling as a common adverse reaction. The distinction between tremor and tics should be clarified through clinical examination. Clinicians should maintain awareness of this potential adverse effect, particularly in adolescents and those with personal or family history of tic disorders.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.